OPSEU Pension Plan Trust Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,628
Closed -$1.49M 305
2022
Q3
$1.49M Sell
23,628
-424
-2% -$29.6K 0.39% 85
2022
Q2
$1.96M Buy
24,052
+1,285
+6% +$122K 0.49% 53
2022
Q1
$2.41M Buy
22,767
+811
+4% +$79K 0.57% 34
2021
Q4
$2.34M Buy
21,956
+81
+0.4% +$8.84K 0.53% 48
2021
Q3
$2.36M Sell
21,875
-1,138
-5% -$118K 0.6% 30
2021
Q2
$2.2M Buy
+23,013
New +$2.12M 0.56% 39

Other funds holding HZNP

OPSEU Pension Plan Trust Fund's HZNP Position: Q4 2022 in Review

OPSEU Pension Plan Trust Fund sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 23,628 shares — an estimated $1.49M sold.

OPSEU Pension Plan Trust Fund first reported a position in HZNP in Q2 2021 and held it in 6 quarters. The position peaked at $2.41M in Q1 2022. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • OPSEU Pension Plan Trust Fund reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • OPSEU Pension Plan Trust Fund sold 23,628 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.49M.
  • OPSEU Pension Plan Trust Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 6 quarters.
  • OPSEU Pension Plan Trust Fund's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.41M in Q1 2022.
  • 615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q4 2022, filed 9 Feb 2023.